Cargando…
Hepatic leukocyte immunoglobulin‐like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1‐TRAF6 pathway
Nonalcoholic fatty liver disease (NAFLD) is an increasingly prevalent liver pathology characterized by hepatic steatosis and commonly accompanied by systematic inflammation and metabolic disorder. Despite an accumulating number of studies, no pharmacological strategy is available to treat this condi...
Autores principales: | Lu, Yao, Jiang, Zhou, Dai, Haijiang, Miao, Rujia, Shu, Jingxian, Gu, Haotian, Liu, Xing, Huang, Zhijun, Yang, Guoping, Chen, Alex F., Yuan, Hong, Li, Ying, Cai, Jingjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900726/ https://www.ncbi.nlm.nih.gov/pubmed/29091299 http://dx.doi.org/10.1002/hep.29633 |
Ejemplares similares
-
LILRB4 regulates the function of decidual MDSCs via the SHP-2/STAT6 pathway during Toxoplasma gondii infection
por: Li, Yuantao, et al.
Publicado: (2023) -
Characterization of the Leucocyte Immunoglobulin-like Receptor B4 (Lilrb4) Expression in Microglia
por: Kretzschmar, Felix, et al.
Publicado: (2021) -
The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains
por: Zhang, Zhiyong, et al.
Publicado: (2015) -
LILRB4, an immune checkpoint on myeloid cells
por: Yang, Ting, et al.
Publicado: (2022) -
A LILRB1 variant with a decreased ability to phosphorylate SHP-1 leads to autoimmune diseases
por: Sinthuwiwat, Thivaratana, et al.
Publicado: (2022)